Assessment and management of acute spinal cord injury: From point of injury to rehabilitation. (2nd November 2017)

• Record Type: Journal Article
• Authors: Hachem, Laureen D.; Ahuja, Christopher S.; Fehlings, Michael G.
• Is Part Of: Journal of spinal cord medicine. Volume 40:Number 6(2017:Nov.)
• Page Start: 665
• Page End: 675
• Publication Date: 2017-11-02
• Subjects: Spinal cord injury -- Stem cell -- Treatment -- Regeneration -- Neuroprotection -- Rehabilitation -- Surgical decompression -- Pathophysiology; Spinal cord -- Wounds and injuries -- Periodicals; Spinal cord -- Diseases -- Periodicals; 616.8305
• DOI: 10.1080/10790268.2017.1329076
• Languages: English
• ISSNs: 1079-0268

Abstract

Abstract : Context : Spinal cord injury (SCI) is a devastating condition that can lead to significant neurological impairment and reduced quality of life. Despite advancements in our understanding of the pathophysiology and secondary injury mechanisms involved in SCI, there are currently very few effective treatments for this condition. The field, however, is rapidly changing as new treatments are developed and key discoveries are made. Methods : In this review, we outline the pathophysiology, management, and long-term rehabilitation of individuals with traumatic SCI. We also provide an in-depth overview of emerging therapies along the spectrum of the translational pipeline. Evidence synthesis : The concept of "time is spine" refers to the concept which emphasizes the importance of early transfer to specialized centers, early decompressive surgery, and early delivery of other treatments (e.g. blood pressure augmentation, methylprednisolone) to affect long-term outcomes. Another important evolution in management has been the recognition and prevention of the chronic complications of SCI including respiratory compromise, bladder dysfunction, Charcot joints, and pressure sores through directed interventions along with early integration of physical rehabilitation and mobilization. There have also been significant advances in neuroprotective and neuroregenerative strategies for SCI, many of which are actively in clinical trial including riluzole, Cethrin, stem cell transplantation, and the use of functional electrical stimulation. Conclusion : Pharmacologic treatments, cell-based therapies, and other technology-driven interventions will likely play a combinatorial role in the evolving management of SCI as the field continues to evolve.